[
  {
    "ts": null,
    "headline": "Revvity (RVTY) Valuation Check After Recent Share Price Rebound And Margins Reset Narrative",
    "summary": "Event context and recent price moves Revvity (RVTY) recently caught investor attention after a period where the share price shows a return of about 14% over the past month and roughly 22% over the past 3 months, despite a negative 1 year total return. See our latest analysis for Revvity. At a share price of $111.13, Revvity is coming off a sharp 30 day share price return of about 14% and a 90 day gain of roughly 22%. However, the 1 year total shareholder return is still close to 10% lower and...",
    "url": "https://finnhub.io/api/news?id=51aed0aee6981513ebfa5f9c9f89542668107d21f20d62aeb7f09bce55188ac2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769710179,
      "headline": "Revvity (RVTY) Valuation Check After Recent Share Price Rebound And Margins Reset Narrative",
      "id": 138298772,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RVTY",
      "source": "Yahoo",
      "summary": "Event context and recent price moves Revvity (RVTY) recently caught investor attention after a period where the share price shows a return of about 14% over the past month and roughly 22% over the past 3 months, despite a negative 1 year total return. See our latest analysis for Revvity. At a share price of $111.13, Revvity is coming off a sharp 30 day share price return of about 14% and a 90 day gain of roughly 22%. However, the 1 year total shareholder return is still close to 10% lower and...",
      "url": "https://finnhub.io/api/news?id=51aed0aee6981513ebfa5f9c9f89542668107d21f20d62aeb7f09bce55188ac2"
    }
  },
  {
    "ts": null,
    "headline": "Will Revvity Q4 Earnings Benefit From Early Signs of Demand Recovery?",
    "summary": "RVTY's Q4 results are likely to benefit from early demand recovery signs in Life Sciences, but China Diagnostics headwinds may limit earnings upside.",
    "url": "https://finnhub.io/api/news?id=8c4c04637fba91d67e1de3f7f530009e915f1529d385d0f625fa27fe3233a4ef",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769709060,
      "headline": "Will Revvity Q4 Earnings Benefit From Early Signs of Demand Recovery?",
      "id": 138298773,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RVTY",
      "source": "Yahoo",
      "summary": "RVTY's Q4 results are likely to benefit from early demand recovery signs in Life Sciences, but China Diagnostics headwinds may limit earnings upside.",
      "url": "https://finnhub.io/api/news?id=8c4c04637fba91d67e1de3f7f530009e915f1529d385d0f625fa27fe3233a4ef"
    }
  }
]